Literature DB >> 9784418

Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3',5'-cyclic nucleotide phosphodiesterase.

M Hayashi1, K Matsushima, H Ohashi, H Tsunoda, S Murase, Y Kawarada, T Tanaka.   

Abstract

We have identified a novel human isozyme of 3',5'-cyclic nucleotide phosphodiesterase (PDE), which we designated PDE8B. cDNA of 2844 bp encoding the C-terminal 659 amino acids of PDE8B was cloned following the identification of an expressed sequence tag (EST) obtained through a search of the EST database. The predicted protein sequences of PDE8B showed highest homology (65% identity, 83% similarity) to that of PDE8A. Northern blot analysis indicated that the mRNA encoding PDE8B is expressed specifically and abundantly in thyroid gland as a approximately 4.2 kb mRNA, in contrast to the wide expression of PDE8A mRNA in various tissues. The carboxyl-terminal 584 amino acids of PDE8B were expressed in E.coli as a fusion protein. The recombinant PDE8B exhibited cAMP PDE activity which was not inhibited by various PDE inhibitors including vinpocetine, milrinone, rolipram, and IBMX with the exception of dipyridamole which caused 50% inhibition at a concentration of 40 microM. cAMP hydrolytic activity was unaffected by cGMP and no cGMP PDE hydrolysis were detectable at concentrations up to 100 microM. These findings suggest that PDE8B is a new member of the PDE8 family. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784418     DOI: 10.1006/bbrc.1998.9379

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  37 in total

Review 1.  Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment.

Authors:  Isaac Levy; Anelia Horvath; Monalisa Azevedo; Rodrigo Bertollo de Alexandre; Constantine A Stratakis
Journal:  Curr Opin Pharmacol       Date:  2011-10-31       Impact factor: 5.547

Review 2.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

3.  The novel distribution of phosphodiesterase-4 subtypes within the rat retina.

Authors:  C M Whitaker; N G F Cooper
Journal:  Neuroscience       Date:  2009-07-26       Impact factor: 3.590

Review 4.  Phosphodiesterases and adrenal Cushing in mice and humans.

Authors:  E Szarek; C A Stratakis
Journal:  Horm Metab Res       Date:  2014-09-18       Impact factor: 2.936

5.  Autosomal-dominant striatal degeneration is caused by a mutation in the phosphodiesterase 8B gene.

Authors:  Silke Appenzeller; Anja Schirmacher; Hartmut Halfter; Sebastian Bäumer; Manuela Pendziwiat; Vincent Timmerman; Peter De Jonghe; Klára Fekete; Florian Stögbauer; Peter Lüdemann; Margret Hund; Elgar Susanne Quabius; E Bernd Ringelstein; Gregor Kuhlenbäumer
Journal:  Am J Hum Genet       Date:  2010-01       Impact factor: 11.025

Review 6.  Regulation of adrenal steroidogenesis by the high-affinity phosphodiesterase 8 family.

Authors:  L-C L Tsai; J A Beavo
Journal:  Horm Metab Res       Date:  2012-08-17       Impact factor: 2.936

7.  Refolding and kinetic characterization of the phosphodiesterase-8A catalytic domain.

Authors:  Zier Yan; Huanchen Wang; Jiwen Cai; Hengming Ke
Journal:  Protein Expr Purif       Date:  2008-10-19       Impact factor: 1.650

8.  Association study of phosphodiesterase genes in the Sequenced Treatment Alternatives to Relieve Depression sample.

Authors:  Michael Cabanero; Gonzalo Laje; Sevilla Detera-Wadleigh; Francis J McMahon
Journal:  Pharmacogenet Genomics       Date:  2009-03       Impact factor: 2.089

9.  Characterization of novel phosphodiesterases in the bovine ovarian follicle.

Authors:  Maxime Sasseville; Firas K Albuz; Nancy Côté; Christine Guillemette; Robert B Gilchrist; François J Richard
Journal:  Biol Reprod       Date:  2009-04-08       Impact factor: 4.285

Review 10.  Selective phosphodiesterase inhibitors: a promising target for cognition enhancement.

Authors:  Olga A H Reneerkens; Kris Rutten; Harry W M Steinbusch; Arjan Blokland; Jos Prickaerts
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.